Latendorf, Ties
Gerstel, Ulrich
Wu, Zhihong
Bartels, Joachim
Becker, Alexander
Tholey, Andreas
Schröder, Jens-Michael
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 877, Z2, Cluster of Excellence, Inflammation at interfaces)
Article History
Received: 18 October 2018
Accepted: 19 December 2018
First Online: 4 March 2019
Competing Interests
: Kiel University has filed a provisional patent application with J.M.S. as inventor. It covers cationic intrinsically disordered antimicrobial peptides (CIDAMPs) as designer peptide antibiotics, as well as the application of CIDAMPs as disinfectants and for the prevention and treatment of bacterial and fungal infections (European Patent Application Number EP16199780.4 “Cationic intrinsically disordered antimicrobial peptides”). All other authors declare no competing interests.